durvalumab
astrazeneca
['pacific']
pacific trial sub-group analysis #asco22 
Vivek Subbiah, MD, (@VivekSubbiah) #PrecisionMedicine Expert and Medical Oncologist, takes over our Twitter today to discuss #ASCO22.